TrueVision announced the appointment of William J. Link, PhD, to its Board of Directors. The appointment is effective immediately.
“TrueVision’s advancement of digital image science for surgery, the quality of their strategic partners, along with its ability to enhance the surgical experience has been spectacular," Dr. Link said in a company news release. “I look forward to working alongside a talented team of innovators and technologists to expand TrueVision’s Digital Surgery Platform to multiple surgical markets, treatments and applications, including growing its impact on ophthalmology.”
Dr. Link has a long history of leadership in business and in the healthcare industry. He is currently the founder and principal of Flying L Partners, a strategic fund focused primarily on ophthalmology. Prior to Flying L Partners, he was a managing director and co-founder of Versant Ventures, a leading venture capital firm, where he spent more than 25 years investing and building some of the most successful and innovative medical device companies. Prior to entering venture capital, he founded Chiron Vision (now part of Bausch + Lomb) and American Medical Optics (now part of J&J Vision). Dr. Link serves on the board of several private and three public companies including Glaukos (GKOS), Second Sight (EYES) and Edwards Life Sciences (EW). He received his BS, MS and PhD in Mechanical Engineering from Purdue University.
“Bill’s experience and perspective will be very valuable at this time of accelerating growth and expanding strategic opportunities,” Fred Gluck, Co-Chairman of TrueVision’s Board of Directors and Managing Partner Emeritus of McKinsey and Company, said in the news release.
“Bill’s reputation and track record of building successful ophthalmic medical device companies is unequaled," Forrest Fleming, TrueVision’s Chief Executive Officer, said in the news release. "His ongoing passion for commercializing big ideas is inspiring. I am very excited about working with him to expand our Digital Surgery Platform to improve surgical outcomes."